David Hinds

Nessuna posizione attualmente

Consumer Services

Finance

Commercial Services

Provenienza dei contatti di primo grado di David Hinds

Entità	Tipo di entità	Settore Industriale
JASPER THERAPEUTICS, INC. 8	Public Company	Financial Conglomerates	8

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a David Hinds tramite i suoi contatti personali

Società	Settore	Persone collegate	Posizione principale
AIMMUNE THERAPEUTICS, INC.	Pharmaceuticals: Major	Daniel Adelman Annette Marcantonio	Chief Tech/Sci/R&D Officer Corporate Officer/Principal
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Biotechnology	Daniel Adelman Edwin Tucker	Chief Tech/Sci/R&D Officer Corporate Officer/Principal
DYNE THERAPEUTICS, INC.	Biotechnology	Lawrence Klein	Director/Board Member
CABALETTA BIO, INC.	Biotechnology	Scott Brun	Director/Board Member
Gold Mast Consulting, LLC		Scott Brun	Founder
Trishula Therapeutics, Inc. Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021.	Pharmaceuticals: Major	Scott Brun	Director/Board Member
Abingworth Management, Inc. Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA.	Investment Managers	Scott Brun	Private Equity Investor
FORTE BIOSCIENCES, INC.	Biotechnology	Scott Brun	Director/Board Member
Accelerator Services Corp Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.	Investment Managers	Scott Brun	Consultant / Advisor
CRISPR THERAPEUTICS AG	Biotechnology	Lawrence Klein	Chief Operating Officer
Mckinsey & Co. (Switzerland) Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Mckinsey & Co. (Switzerland) provides business management consulting services. The private company is based in Geneva, Switzerland.	Miscellaneous Commercial Services	Lawrence Klein	Corporate Officer/Principal
Stanford University	College/University	Lawrence Klein	Doctorate Degree
University of Wisconsin	College/University	Lawrence Klein	Undergraduate Degree
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.	Investment Managers	Lawrence Klein	Private Equity Investor
University of Illinois At Urbana–Champaign	College/University	Scott Brun	Undergraduate Degree
MIRUM PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Edwin Tucker	Chief Tech/Sci/R&D Officer
University of Leeds	College/University	Edwin Tucker	Doctorate Degree
The Royal College of Physicians	College/University	Edwin Tucker	Corporate Officer/Principal
University of Connecticut	College/University	Edwin Tucker	Masters Business Admin
Acerta Pharma LLC		Edwin Tucker	Compliance Officer
JOHNSON & JOHNSON	Pharmaceuticals: Major	Edwin Tucker	Corporate Officer/Principal
AGENUS INC.	Biotechnology	Patricia Carlos	General Counsel
ARCUS BIOSCIENCES, INC.	Biotechnology	Patricia Carlos	General Counsel
Memorial University of Newfoundland	College/University	Patricia Carlos	Undergraduate Degree
TRICIDA, INC.	Pharmaceuticals: Major	Matthew Ford	Human Resources Officer
The Johns Hopkins University School of Medicine	College/University	Scott Brun	Doctorate Degree
ABBVIE INC.	Pharmaceuticals: Major	Scott Brun	Corporate Officer/Principal
Axial Therapeutics, Inc. Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA.	Pharmaceuticals: Major	Scott Brun	Director/Board Member
Arthur Andersen LLP Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.	Miscellaneous Commercial Services	Herbert Cross	Corporate Officer/Principal
AFFYMAX, INC.	Biotechnology	Herbert Cross	Director of Finance/CFO
HUMANIGEN, INC.	Biotechnology	Herbert Cross	Chief Executive Officer
ARMO BIOSCIENCES INC	Pharmaceuticals: Major	Herbert Cross	Director of Finance/CFO
Balance Therapeutics, Inc. Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA.	Biotechnology	Herbert Cross	Director of Finance/CFO
ATRECA, INC.	Biotechnology	Herbert Cross	Director of Finance/CFO
Apexigen America, Inc. Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.	Pharmaceuticals: Major	Herbert Cross	Director/Board Member
DNAtrix, Inc. DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.	Electronic Equipment/Instruments	Herbert Cross	Director/Board Member
APEXIGEN, INC.	Biotechnology	Herbert Cross	Director/Board Member
Haas School of Business	College/University	Herbert Cross	Undergraduate Degree
American Society of Clinical Oncology, Inc. American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.	Medical/Nursing Services	Daniel Adelman	Corporate Officer/Principal
PDL BIOPHARMA, INC.	Biotechnology	Herbert Cross	Comptroller/Controller/Auditor
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.	Miscellaneous Commercial Services	Daniel Adelman	Corporate Officer/Principal
American Society of Hematology American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC.	Miscellaneous Commercial Services	Daniel Adelman	Corporate Officer/Principal
PHARMACYCLICS, INC.	Pharmaceuticals: Major	Daniel Adelman	Chief Tech/Sci/R&D Officer
University of California, Berkeley	College/University	Daniel Adelman	Undergraduate Degree
University of California, Davis	College/University	Daniel Adelman	Doctorate Degree